首页 文献索引 SCI期刊 AI助手
期刊目录筛选

期刊名:Cancer investigation

缩写:CANCER INVEST

ISSN:0735-7907

e-ISSN:1532-4192

IF/分区:2.2/Q3

文章目录 更多期刊信息

共收录本刊相关文章索引1679条
Clinical Trial Case Reports Meta-Analysis RCT Review Systematic Review
Classical Article Case Reports Clinical Study Clinical Trial Clinical Trial Protocol Comment Comparative Study Editorial Guideline Letter Meta-Analysis Multicenter Study Observational Study Randomized Controlled Trial Review Systematic Review
Murat Koçer,Mustafa Nazıroğlu,Gülperi Koçer et al. Murat Koçer et al.
We investigated the effects of bisphosphonate (BP) on oxidative stress levels in blood of patients with cancer. In total, 19 patients with cancer and 21 healthy subjects were included in the study. BP was intravenously administrated to the ...
Jianping Wu,Jun Liu,Ruipeng Jia et al. Jianping Wu et al.
Currently, bladder cancer ranks as the second most common genitourinary malignancy which is exacting significant morbidity and mortality worldwide. Although there are abundant epidemiological and basic studies which strongly suggest the rol...
Marcos Vinícius Macedo de Oliveira,João Marcus Oliveira Andrade,Alanna Fernandes Paraíso et al. Marcos Vinícius Macedo de Oliveira et al.
Sirtuins are involved in the control of the cell cycle and regulation of gene transcription. While some sirtuins have tumor suppressor effects, others regulate tumors metabolism. Within this perspective, the present article is a review of t...
Gaofeng Jiang,Zhixiong Huang,Shuangling Zhang et al. Gaofeng Jiang et al.
The role of genetic alterations in PIK3CA gene has not been fully explored in ovarian clear cell carcinoma (OCCC). The present study was undertaken to assess mutations and amplifications of exons 9 and 20 of PIK3CA in 51 Chinese OCCC patien...
Iwona Wzietek,Rafal Suwinski,Elzbieta Nowara et al. Iwona Wzietek et al.
We performed the analysis of database on 409 patients with LD-SCLC to evaluate as to what extent the clinical outcome of large prospective trials was reproduced in routine practice. The analysis has shown that the hazard rate of death in th...
Konstantinos I Tsamis,George A Alexiou,Evrysthenis Vartholomatos et al. Konstantinos I Tsamis et al.
Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) exhibits cancer-selective killing activity representing a promising anticancer therapeutic strategy. Adenovirus Delta-24 is another interested anticancer agent selectively kill...
Hanbyoul Cho,You Sun Lee,Julie Kim et al. Hanbyoul Cho et al.
Illumina microarray was used to identify differentially expressed genes in three epithelial ovarian cancer (EOC) cells. To validate the microarray data, mRNA and protein level of glucose transporter-1 (GLUT-1) was examined. GLUT-1 had an EO...
Malcolm D Mattes,Justin M Mann,Hani Ashamalla et al. Malcolm D Mattes et al.
This study assessed whether routine pathologic parameters could predict Oncotype DX(TM) recurrence score (RS) in 72 breast cancers diagnosed from 2008-2012. Comparing patients with low RS (0-17) vs. intermediate RS (18-30) vs. high RS (>30)...
D Matthaios,P Hountis,P Karakitsos et al. D Matthaios et al.
Histone's H2A variant (H2AX) phosphorylation is an early indicator of DNA double-strand breaks formation and DNA damage response. Thus, it may act as a novel biomarker to monitor genotoxic events that can drive cancer development and tumor ...
Rafael Alvarez-Gonzalez,Hilda Mendoza-Alvarez,Manfred Frey et al. Rafael Alvarez-Gonzalez et al.
We used a [(32)P] p53 sequence-specific oligodeoxynucleotide and Electrophoretic-Mobility-Shift-Assays to monitor p53 DNA sequence-specific binding with p53-R267W, a nonbinding point mutant; and p53-Δ30, a deletion-mutant which lacks the c...